This is a demo store. No orders will be fulfilled.
Healthcare
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
26 Oct 2021  |  Global  |  Customer Research
Hybrid and Multicloud Healthcare IT Transformation
Findings from the 2020 Frost & Sullivan Global Cloud User Survey
Healthcare providers are accelerating digitization strategies due to the COVID-19 pandemic. The most successful providers leverage cloud computing to meet business agility, cost savings, innovation, data storage, security, and privacy goals. Frost & Sullivan conducted the 2020 Global Cloud User Survey between August and September 2020 in North A...
$4,950.00 -
26 Mar 2021  |  North America  |  Customer Research
Global Laboratory Product Purchasing Trends, 2020–2021
An End-user Perspective on Laboratory Spending Reveals Modest 2021 Budget Increases Following Healthier 2020 Spending
Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2020 that centered on the state of their laboratories in 2020 and their expectations for 2021. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents yea...
$4,950.00 -
09 Jan 2017  |  North America  |  Customer Research
2016 Global Survey on Clinical Next-Generation Sequencing
Respondents Show Vivid Interest in Developing Clinical NGS-based Tests for Infectious Disease Testing Applications
The primary goal of this research is to analyze the current and future adoption plans of Next-Generation Sequencing (NGS) for clinical applications. The survey seeks to collect the following key information: • Outsourcing needs and clinical NGS service providers • Current and future interest areas of clinical NGS • Genetic elements of in...
$4,950.00 -
21 Dec 2012  |  North America  |  Customer Research
2013 Projected Global Laboratory Products Budgets
Brands Named, Purchasing Trends Identified
This survey of 170 laboratory managers and researchers investigates budgets for these product categories: instruments, equipment, chemicals, life science reagents and kits, glassware, plasticware, and general laboratory supplies over the 2011-2013 period. Budgets for service and repair of instruments and equipment also are presented. Additionally,...
$10,000.00 -
26 Nov 2012  |  North America  |  Customer Research
Global Quantitative and dPCR Instrumentation and Consumables Purchasing Trends
Opportunities Within Organizations
The primary objective of this research is to identify trends for quantitative polymerase chain reaction (PCR) techniques, specifically the use of nascent digital PCR (dPCR) technology in comparison with the mature real-time quantitative PCR (qPCR) technology. The research strives to compare differences of current and future use between qPCR and dPC...
$10,000.00 -
27 Sep 2012  |  North America  |  Customer Research
2009 United States Oncology Drug Delivery Patterns, Preferences, and Opportunities
Volume 1: Oncologist and Infusion Nurse Perspectives
Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. This customer research was completed to understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients; identify physicians prescribing trends relative to delivery considerations; understand the role of reimburs...
$10,000.00 -
31 Jul 2012  |  North America  |  Customer Research
Understanding the Peripheral Intervention Toolkit
An Analysis of Trends, Strategies, and Opportunities in the U.S. Peripheral Intervention Market
In February 2010, Frost & Sullivan surveyed 157 vascular surgeons, interventional cardiologists, and interventional radiologists on a broad range of issues relating to peripheral intervention procedures. This study is based on their responses to an extensive online questionnaire. The study addresses balloons and stents, atherectomy devices, thrombe...
$10,000.00 -
24 May 2012  |  North America  |  Customer Research
Purchasing Trends in the Research Antibodies Market
Evaluating Budgets, Suppliers, and Unmet Needs
This study is based on input from 1,155 laboratory personnel who either participate in their laboratory's purchase of antibodies or are users of antibodies. Most survey participants are located in the United States, although participation was open to researchers globally. The objectives of this research are to identify points such as: types of rese...
$10,000.00 -
08 May 2012  |  North America  |  Customer Research
Global Laboratory Product Purchasing Trends
A Survey of Laboratory Managers, Directors, Technicians, and Scientists
This study is based on a survey of 151 laboratory professionals working in a variety of laboratory types. They reveal their laboratories' current (2011) budgets and anticipated budget trends (for 2012) in seven product categories, and the top brands in each of these categories. The product categories and the brand with the highest unaided brand rec...
$10,000.00 -
26 Mar 2012  |  North America  |  Customer Research
Investment Confidence Among Laboratory Decision Makers
In What Laboratory Products do Decision Makers Expect to Invest?
The study investigates investment decisions of healthcare-related laboratory decision makers. It shows that 2011 was tumultuous for the laboratory industry. In comparison, the outlook for 2012 looks only slightly positive. In particular, laboratory decision makers generally expect their funding conditions to either remain the same or minimally impr...
$10,000.00